These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


67 related items for PubMed ID: 16201924

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Broad spectrum beta-lactamases of Citrobacter diversus.
    Oliva B, Segatore B, Amicosante G, Franceschini N, Oratore A, Bennett PM.
    J Antimicrob Chemother; 1990 Mar; 25(3):335-41. PubMed ID: 2338412
    [Abstract] [Full Text] [Related]

  • 23. AmpC beta-lactamase producing bacterial isolates from Kolkata hospital.
    Arora S, Bal M.
    Indian J Med Res; 2005 Sep; 122(3):224-33. PubMed ID: 16251779
    [Abstract] [Full Text] [Related]

  • 24. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria.
    Park YJ, Park SY, Oh EJ, Park JJ, Lee KY, Woo GJ, Lee K.
    Diagn Microbiol Infect Dis; 2005 Apr; 51(4):265-9. PubMed ID: 15808318
    [Abstract] [Full Text] [Related]

  • 25. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China.
    Chen S, Hu F, Liu Y, Zhu D, Wang H, Zhang Y.
    Am J Infect Control; 2011 Nov; 39(9):e55-60. PubMed ID: 21705111
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Detection of KPC-2-producing Citrobacter freundii isolates in Spain.
    Gómez-Gil MR, Paño-Pardo JR, Romero-Gómez MP, Gasior M, Lorenzo M, Quiles I, Mingorance J.
    J Antimicrob Chemother; 2010 Dec; 65(12):2695-7. PubMed ID: 20851814
    [No Abstract] [Full Text] [Related]

  • 30. Companion animals: a relevant source of extended-spectrum β-lactamase-producing fluoroquinolone-resistant Citrobacter freundii.
    Ewers C, Bethe A, Wieler LH, Guenther S, Stamm I, Kopp PA, Grobbel M.
    Int J Antimicrob Agents; 2011 Jan; 37(1):86-7. PubMed ID: 21074371
    [No Abstract] [Full Text] [Related]

  • 31. Dependence of induction of enterobacterial AmpC beta-lactamase on cell-wall peptidoglycan, as demonstrated in Proteus mirabilis and its wall-less protoplast L-form.
    Tölg M, Schmidt H, Schierl R, Datz M, Martin HH.
    J Gen Microbiol; 1993 Nov; 139(11):2715-22. PubMed ID: 8277255
    [Abstract] [Full Text] [Related]

  • 32. CMY-20, a novel AmpC-type beta-lactamase from South African clinical Escherichia coli isolates.
    Mocktar C, Govinden U, Sturm AW, Essack SY.
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):405-8. PubMed ID: 18207348
    [Abstract] [Full Text] [Related]

  • 33. Identification of ACT-1 plasmid-mediated AmpC β-lactamase producing Citrobacter freundii from a Chinese patient.
    Wei Y, Wang J.
    Ann Lab Med; 2013 Jan; 33(1):86-8. PubMed ID: 23301230
    [No Abstract] [Full Text] [Related]

  • 34. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
    Jørgensen RL, Nielsen JB, Friis-Møller A, Fjeldsøe-Nielsen H, Schønning K.
    J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
    [Abstract] [Full Text] [Related]

  • 35. Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysis.
    Oefner C, D'Arcy A, Daly JJ, Gubernator K, Charnas RL, Heinze I, Hubschwerlen C, Winkler FK.
    Nature; 1990 Jan 18; 343(6255):284-8. PubMed ID: 2300174
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants.
    Mett H, Rosta S, Schacher B, Frei R.
    Rev Infect Dis; 1988 Jan 18; 10(4):765-9. PubMed ID: 3263685
    [Abstract] [Full Text] [Related]

  • 39. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
    Okamoto K, Gotoh N, Nishino T.
    Antimicrob Agents Chemother; 2001 Jul 18; 45(7):1964-71. PubMed ID: 11408209
    [Abstract] [Full Text] [Related]

  • 40. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase.
    Fernández-Cuenca F, Rodríguez-Martínez JM, Martínez-Martínez L, Pascual A.
    Int J Antimicrob Agents; 2006 Jun 18; 27(6):549-52. PubMed ID: 16697150
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.